GGrantIndex
Sort

17,828 grants matching crispr

Targeting Inflammasome with stable endocannabinoid ligand AMG315. CRISPR/Cas9 and nanotechnology study in the context of HIV and cannabinoid

$370,861
Madhavan P Nair · Florida International University · R01 · FY2022 · DA

Overcoming chemoresistance in triple negative breast cancer

$370,836
Ozgur Sahin · Medical University Of South Carolina · R01 · FY2025 · CA

Abbreviated targeted therapy to improve anti-PD-1 inhibitor efficacy in melanoma

$370,800
Ryan J Sullivan · Massachusetts General Hospital · R01 · FY2019 · CA

Master regulator transcription factors promote esophageal neoplastic evolution

$370,711
De-Chen Lin · University Of Southern California · R37 · FY2024 · CA

The Metabolic Regulation of Melanoma Metastasis

$370,699
Sean J Morrison · Ut Southwestern Medical Center · U01 · FY2019 · CA

Project 4: Identification of Essential Genes Underlying AR Activity in Antagonist-Resistant CRPC

$370,664
Myles A Brown · Beth Israel Deaconess Medical Center · P01 · FY2023 · CA

Understanding the Relationship LNP Structure, Cholesterol Trafficking, and InVivo Delivery

$370,620
James Dahlman · Georgia Institute Of Technology · R01 · FY2020 · GM

Targeting Inflammasome with stable endocannabinoid ligand AMG315. CRISPR/Cas9 and nanotechnology study in the context of HIV and cannabinoid

$370,610
Madhavan P Nair · Florida International University · R01 · FY2023 · DA

Project 4: Novel epigenetic treatment of IDH mutant gliomas

$370,528
Harley I Kornblum · University Of California Los Angeles · P50 · FY2018 · CA

Project 4: Identification of Essential Genes Underlying AR Activity in Antagonist-Resistant CRPC

$370,489
Myles A Brown · Beth Israel Deaconess Medical Center · P01 · FY2022 · CA

Enhancing Genome Editing Technology with Natural Cas9 Inhibitors

$370,461
Erik J Sontheimer · Univ Of Massachusetts Med Sch Worcester · R01 · FY2018 · GM

Targeting Inflammasome with stable endocannabinoid ligand AMG315. CRISPR/Cas9 and nanotechnology study in the context of HIV and cannabinoid

$370,347
Madepalli Krishnappa Lakshmana · Florida International University · R01 · FY2024 · DA

Regulatory Core

$370,333
Cathy Rasmussen · University Of Wisconsin-Madison · U19 · FY2024 · NS

Efficient Measurement and Characterization of Genetic Interactions in Cancer Cells

$370,173
Glen Traver Hart · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA

The immune regulation of macrophage antibody dependent cellular phagocytosis

$370,159
Adam David Hoppe · South Dakota State University · U01 · FY2021 · AI

Aldh2 and epithelial homeostasis and pathobiology

$370,125
Hiroshi Nakagawa · Columbia University Health Sciences · R01 · FY2024 · AA

Aldh2 and epithelial homeostasis and pathobiology

$370,125
Hiroshi Nakagawa · Columbia University Health Sciences · R01 · FY2025 · AA

Metabolic and Bioenergetic Control in Mitochondrial Diseases

$370,092
Pere Puigserver · Dana-Farber Cancer Inst · R01 · FY2020 · GM

Metabolic and Bioenergetic Control in Mitochondrial Diseases

$370,092
Pere Puigserver · Dana-Farber Cancer Inst · R01 · FY2017 · GM

Metabolic and Bioenergetic Control in Mitochondrial Diseases

$370,092
Pere Puigserver · Dana-Farber Cancer Inst · R01 · FY2018 · GM

Metabolic and Bioenergetic Control in Mitochondrial Diseases

$370,092
Pere Puigserver · Dana-Farber Cancer Inst · R01 · FY2019 · GM

Studies of Hereditary Neurological Disease: Disease Mechanisms

$370,084
Kenneth Fischbeck · National Institute Of Neurological Disorders And Stroke · ZIA · FY2023 · NS

Determinants of Enteric Calicivirus Infection.

$370,000
Tibor Farkas · Louisiana State Univ A&M Col Baton Rouge · R01 · FY2019 · AI

Bacteriophage diversity, dynamics, function, and exploitation

$369,945
Graham F. Hatfull · University Of Pittsburgh At Pittsburgh · R35 · FY2019 · GM

Residual disease: unraveling immunosurveillance and immune evasion of disseminated tumor cells

$369,883
Joan Massague · Sloan-Kettering Inst Can Research · U54 · FY2016 · CA